Fundz

Imv Inc. reported raising in an initial SEC Form D filing, from an offering of $750,000

PRIVATEJan 03, 2022$0 of $750K raised

Round Type

Venture

DartmouthBiotechnologyHealthcareHealth Care

Quick answer

IMV raised an undisclosed amount in a funding round, dated January 3, 2022. IMV is based in Dartmouth, Nova Scotia, Canada.

How much did IMV raise?
IMV raised an undisclosed amount in a funding round on January 3, 2022.
What does IMV do?
IMV Inc. is a Canadian biotechnology company known for its innovative DPX™ immune educating platform technology.
Where is IMV based and how big is it?
IMV is based in Dartmouth, Nova Scotia, Canada.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as IMV that raised within 45 days of this round, from Fundz verified event records.

  • Azora Therapeutics, Inc. (DE) raised $10M on February 17, 2022.
  • Azora Therapeutics, Inc. (DE) raised $10M (Funding Round) on February 16, 2022.
  • Avenda Health, Inc. raised $6.4M on February 11, 2022.
  • MindImmune Therapeutics raised $5.3M on February 4, 2022.
  • Passage Bio raised $4M (Seed) on February 1, 2022.
  • Reimagine Care raised $25M (Series A) on January 25, 2022.

Who to call at IMV, and when

A new round usually means IMV is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day IMV raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at IMV, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at IMV. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

IMV

Location

Dartmouth, Nova Scotia, Canada

About

IMV Inc. is a Canadian biotechnology company known for its innovative DPX™ immune educating platform technology. It has been involved in the discovery, preclinical, and clinical development of assets in the fields of oncology, infectious disease, and antigen desensitization. IMV Inc. has a proven track record of developing novel immunotherapeutic solutions and advancing clinical-stage assets for the benefit of patients worldwide.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment IMV raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for IMV's next move

See what Strategic adds

IMV raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.